Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to 0.81.

  • Ocular Therapeutix's Equity Ratio rose 1758.74% to 0.81 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.81, marking a year-over-year increase of 1758.74%. This contributed to the annual value of 0.81 for FY2025, which is 1758.74% up from last year.
  • According to the latest figures from Q4 2025, Ocular Therapeutix's Equity Ratio is 0.81, which was up 1758.74% from 0.63 recorded in Q3 2025.
  • Over the past 5 years, Ocular Therapeutix's Equity Ratio peaked at 0.81 during Q4 2025, and registered a low of 0.03 during Q2 2023.
  • Moreover, its 5-year median value for Equity Ratio was 0.41 (2021), whereas its average is 0.45.
  • Its Equity Ratio has fluctuated over the past 5 years, first plummeted by 9337.52% in 2023, then surged by 279987.51% in 2024.
  • Quarter analysis of 5 years shows Ocular Therapeutix's Equity Ratio stood at 0.43 in 2021, then plummeted by 44.82% to 0.24 in 2022, then soared by 52.56% to 0.36 in 2023, then skyrocketed by 90.47% to 0.69 in 2024, then rose by 17.59% to 0.81 in 2025.
  • Its Equity Ratio was 0.81 in Q4 2025, compared to 0.63 in Q3 2025 and 0.68 in Q2 2025.